EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid detection of β-lactamase activity using the rapid Amp NP test

Patrice Nordmann iD, Nicolas Helsens iD, Nicolas Kieffer, Camille Tinguely, Gilbert Greub iD, Laurent Poirel iD

Microbiology Spectrum · 2025-04 · 13 (4)

DOI: 10.1128/spectrum.00782-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025-04. Verfasst von Patrice Nordmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: European Institute for Emerging Antibiotic Resistance, University of Fribourg, Fribourg, Switzerland. Hauptthemen laut MEDLINE: beta-Lactamases, Gram-Negative Bacteria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary tract infections (UTIs) are the most common bacterial infections in humans. They are mainly caused by Escherichia coli and other Enterobacterales for which increasing resistance to antibiotics and in particular to β-lactams is extensively reported. The detection of β-lactam resistance phenotypes is currently time-consuming (18 h). Hence, most treatments are given without any results of antibiotic susceptibility testing and may involve broad-spectrum antibiotics. A biochemical diagnostic test has been developed to rapidly evaluate the production of β-lactamases (and consequently the β-lactam resistance) from cultures (10 4 and 10 5 CFU/mL) of Gram-positive and Gram-negative isolates representative of bacterial species as a source of UTIs ( n = 112). It relies on a centrifugation step after a 90 min preliminary culture and the detection of β-lactamase activity with nitrocefin as substrate using a special filter. Overall, the test gave a positive result for 87.6% of the tested resistant strains with a bacterial load of 10 5 CFU/mL, and a positive result for 100% of tested extended-spectrum β-lactamases and for carbapenemase producers at the same load. This cost-effective test can be performed in any laboratory and ultimately shall be tested at the patient side and at the general practitioner. Its turn-around-time to get results is less than 2 h. After further improvements, the results obtained with this proof-of-concept test suggest that its use may contribute to rapidly guide the treatment of non-complicated UTIs and, therefore, limit the use of broad-spectrum antibiotics and the emergence of antibiotic resistance. IMPORTANCE This work reports on a totally novel diagnostic technique, the Rapid Amp NP test for the identification of amoxicillin/ampicillin resistance in bacteria that are sources of non-complicated urinary tract infections. Those preliminary results obtained with cultured bacteria are promising. We believe its future use may contribute to reconsider aminopenicillins as a first line therapy for treating UTI infections. The corresponding patent of this test obtained both for the United States and Europe may contribute to its further industrialization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesGram-Negative BacteriaUrinary Tract InfectionsHumansAnti-Bacterial AgentsMicrobial Sensitivity Testsbeta-Lactam ResistanceCephalosporinsBacterial ProteinsEscherichia coliGram-Positive Bacteria

Stichwörter der Autor:innen

Gram negativeUTIrapid diagnostic testβ-lactamase

Substanzen

beta-LactamasesAnti-Bacterial AgentsnitrocefinCephalosporinsBacterial Proteins

Autor:innen und Institutionen

  • European Institute for Emerging Antibiotic Resistance, University of Fribourg, Fribourg, Switzerland.
  • Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
  • Institute for Microbiology, University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Clinical Microbiology Unit, Pasteur Institute of Lille, Lille, France.

ORCID-Profile: Patrice Nordmann, Nicolas Helsens, Gilbert Greub, Laurent Poirel

Zitieren

APA

Nordmann, P., Helsens, N., Kieffer, N., Tinguely, C., Greub, G., & Poirel, L. (2025). Rapid detection of β-lactamase activity using the rapid Amp NP test. Microbiology Spectrum, 13(4). https://doi.org/10.1128/spectrum.00782-24

Vancouver

Nordmann P, Helsens N, Kieffer N, Tinguely C, Greub G, Poirel L. Rapid detection of β-lactamase activity using the rapid Amp NP test. Microbiology Spectrum. 2025;13(4). doi:10.1128/spectrum.00782-24

BibTeX
@article{Nordmann2025,
  author = {Nordmann, Patrice and Helsens, Nicolas and Kieffer, Nicolas and Tinguely, Camille and Greub, Gilbert and Poirel, Laurent},
  title = {Rapid detection of β-lactamase activity using the rapid Amp NP test},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {4},
  doi = {10.1128/spectrum.00782-24}
}
Kostenlos starten →